Psychometric Evaluation of the Sophia Observation Withdrawal Symptoms Scale in Critically Ill Children
Authors:
- Matthijs de HoogMHMatthijs de Hoog
- Dick TibboelDTDick Tibboel
- Hugo J. DuivenvoordenHDHugo J. Duivenvoorden
- Monique van DijkMDMonique van Dijk
- 1 October 2013
- journal article
- research article
- Published by Wolters Kluwer Health in Pediatric Critical Care Medicine
- Vol. 14 (8) , 761-769
Abstract
The Sophia Observation withdrawal Symptoms scale is an instrument for screening benzodiazepine and opioid withdrawal syndrome in pediatric critical care patients. The objectives of this study were to establish cutoff scores and to test sensitivity to change. Second, risk factors for withdrawal syndrome were explored. Prospective observational study with repeated measures. Level IV ICU at a university children's hospital. A total of 154 children with median age 5 months (interquartile range, 0-42 mo) who received continuous infusion of benzodiazepines and/or opioids for 5 or more days. None. Nurses repeatedly applied the Sophia Observation withdrawal Symptoms scale and the Numeric Rating Scale withdrawal when children were weaned off benzodiazepines and opioids. The latter represents the nurse's expert opinion. We analyzed 3,754 paired assessments; the median number per child was 15 (interquartile range, 7-31) over a median of 5 days (interquartile range, 3-11 d). Sensitivity and specificity were 0.83 and 0.93, respectively, for the Sophia Observation withdrawal Symptoms scale cutoff score of 4 or higher against a Numeric Rating Scale-withdrawal score of 4 or higher. Sensitivity to change was determined by comparing 156 Sophia Observation withdrawal Symptoms scale assessments (n = 51 patients) before and after additional sedatives or opioids. Multilevel regression analysis showed a mean decline of 1.5 points (at score range 0-15) after intervention (p < 0.0001). Logistic regression analysis identified duration of preweaning of midazolam, duration of weaning of midazolam, duration of preweaning of morphine, duration of weaning of morphine, and number of additional sedatives/opioids as statistically significant risk factors for withdrawal syndrome in these children. The Sophia Observation withdrawal Symptoms scale is a valid tool with good psychometric properties to assess withdrawal symptoms in PICU patients.Keywords
This publication has 41 references indexed in Scilit:
- Randomized controlled trial of interrupted versus continuous sedative infusions in ventilated childrenPediatric Critical Care Medicine, 2012
- Adherence to Sedation Withdrawal Protocols and Guidelines in Ventilated PatientsClinical Nurse Specialist, 2012
- The effect of critical illness and inflammation on midazolam therapy in children*Pediatric Critical Care Medicine, 2012
- Validity and generalizability of the Withdrawal Assessment Tool-1 (WAT-1) for monitoring iatrogenic withdrawal syndrome in pediatric patientsPain, 2012
- Tolerance and Withdrawal From Prolonged Opioid Use in Critically Ill ChildrenPediatrics, 2010
- Weaning of opioids and benzodiazepines at home after critical illness in infants: A cost-effective approachJournal of Opioid Management, 2010
- The Withdrawal Assessment Tool–1 (WAT–1): An assessment instrument for monitoring opioid and benzodiazepine withdrawal symptoms in pediatric patients*Pediatric Critical Care Medicine, 2008
- Pediatric delirium in critical illness: phenomenology, clinical correlates and treatment response in 40 cases in the pediatric intensive care unitIntensive Care Medicine, 2007
- Current United Kingdom sedation practice in pediatric intensive carePediatric Anesthesia, 2007
- Paradoxical reaction following intravenous midazolam premedication in pediatric patients – a randomized placebo controlled trial of ketamine for rapid tranquilizationPediatric Anesthesia, 2004